ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Immuneering Announces Closing of its Upsized Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
August 04, 2021Immuneering today announced the closing of its upsized initial public offering of 8,625,000 shares of Class A common stock, including the full exercise by the underwriters of their overallotment option to purchase 1,125,000 shares of Class A common stock -
DDF, Immuneering form $1.3m Alzheimer’s research collaboration
June 21, 2018Britain’s Dementia Discovery Fund has formed a research collaboration with US group Immuneering Corporation that aims to identify novel drug targets and candidates for Alzheimer's disease.
Pharma Sources Insight January 2025
